Consensus ABIONYX Pharma Börse Stuttgart

Equities

609 FR0012616852

Delayed Börse Stuttgart Other stock markets 12:56:04 21/05/2024 pm IST			5-day change	1st Jan Change
1.042 ^EUR	+0.77%		+5.40%	-42.18%

14/03	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
11/03	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

eb6ff074d0e8f288d.EC0G7GUVlsL2g-ybRw4yn8lM5vrNFDaMCTkUv3Elh54.dHpshidDoIHDxaXULXYf8aM6sKj8YnnjSFBt1hxsw8hhGUWeFizcgMbRrQ~532cba4be2ecc441c2fb6b35e8740a35

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.092 EUR

Average target price

10.5 EUR

Spread / Average Target

+861.54%

High Price Target

10.5 EUR

Spread / Highest target

+861.54%

Low Price Target

10.5 EUR

Spread / Lowest Target

+861.54%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar